SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $124,263 | -22.4% | 177,900 | 0.0% | 0.08% | -22.7% |
| Q4 2022 | $160,110 | -85.0% | 177,900 | 0.0% | 0.11% | -83.8% |
| Q3 2022 | $1,067,000 | +80.2% | 177,900 | +24.5% | 0.68% | +67.3% |
| Q2 2022 | $592,000 | +9.0% | 142,900 | 0.0% | 0.41% | +57.8% |
| Q1 2022 | $543,000 | -15.6% | 142,900 | 0.0% | 0.26% | +35.8% |
| Q4 2021 | $643,000 | -3.5% | 142,900 | 0.0% | 0.19% | -10.8% |
| Q3 2021 | $666,000 | – | 142,900 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,711,286 | $22,268,000 | 3.58% |
| NEA Management Company, LLC | 3,142,958 | $18,858,000 | 0.94% |
| Vivo Capital, LLC | 1,232,394 | $7,394,000 | 0.82% |
| RA Capital Management | 5,914,252 | $35,486,000 | 0.76% |
| Nan Fung Group Holdings Ltd | 177,900 | $1,067,000 | 0.68% |
| Ikarian Capital, LLC | 400,000 | $2,400,000 | 0.48% |
| SAMLYN CAPITAL, LLC | 2,929,195 | $17,575,000 | 0.33% |
| EAM Investors, LLC | 149,029 | $894,000 | 0.19% |
| TPG GP A, LLC | 1,885,939 | $11,316,000 | 0.18% |
| Ikarian Capital, LLC | 136,059 | $815,000 | 0.16% |